Yolla Haibe

594 total citations
15 papers, 404 citations indexed

About

Yolla Haibe is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Yolla Haibe has authored 15 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Yolla Haibe's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Yolla Haibe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Yolla Haibe collaborates with scholars based in Lebanon, United States and Tunisia. Yolla Haibe's co-authors include Ali Shamseddine, Deborah Mukherji, Sally Temraz, Malek Kreidieh, Ibrahim Khalifeh, Hiba El Hajj, Youssef Bouferraa, Ziad El Husseini, Farah Naja and Arafat Tfayli and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and BMC Cancer.

In The Last Decade

Yolla Haibe

14 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yolla Haibe Lebanon 8 196 155 106 51 49 15 404
Jia Gu China 12 184 0.9× 116 0.7× 136 1.3× 36 0.7× 99 2.0× 33 428
Shibo Yu China 10 175 0.9× 92 0.6× 124 1.2× 112 2.2× 42 0.9× 26 367
Ailing Zhong China 13 192 1.0× 124 0.8× 104 1.0× 59 1.2× 23 0.5× 29 355
Xinchang Lu China 12 200 1.0× 99 0.6× 94 0.9× 111 2.2× 44 0.9× 25 376
Lizhe Zhu China 12 192 1.0× 110 0.7× 104 1.0× 119 2.3× 41 0.8× 37 381
Shangdan Xie China 11 258 1.3× 121 0.8× 163 1.5× 63 1.2× 53 1.1× 17 462
Yanping Zhong China 14 161 0.8× 172 1.1× 83 0.8× 74 1.5× 72 1.5× 37 476
Zhenling Li China 14 280 1.4× 63 0.4× 98 0.9× 36 0.7× 34 0.7× 40 465
Maryam Qasim Mohammed Iraq 6 166 0.8× 81 0.5× 112 1.1× 99 1.9× 37 0.8× 18 360
V. R. Rozados Argentina 9 119 0.6× 160 1.0× 106 1.0× 61 1.2× 65 1.3× 13 355

Countries citing papers authored by Yolla Haibe

Since Specialization
Citations

This map shows the geographic impact of Yolla Haibe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolla Haibe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolla Haibe more than expected).

Fields of papers citing papers by Yolla Haibe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolla Haibe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolla Haibe. The network helps show where Yolla Haibe may publish in the future.

Co-authorship network of co-authors of Yolla Haibe

This figure shows the co-authorship network connecting the top 25 collaborators of Yolla Haibe. A scholar is included among the top collaborators of Yolla Haibe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolla Haibe. Yolla Haibe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bouferraa, Youssef, et al.. (2023). Thrombotic Microangiopathy in the Setting of Colorectal Cancer: A Therapeutic Challenge with a Bad Prognosis. SHILAP Revista de lepidopterología. 15(1). 9–16.
2.
Bouferraa, Youssef, et al.. (2022). From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade. Frontiers in Oncology. 12. 804983–804983. 8 indexed citations
3.
Bouferraa, Youssef, Yolla Haibe, Maya Charafeddine, et al.. (2022). The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study. BMC Cancer. 22(1). 27–27. 4 indexed citations
4.
Bouferraa, Youssef, Yolla Haibe, Maya Charafeddine, et al.. (2021). Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity. Journal of Clinical and Experimental Hepatology. 12(2). 448–453. 3 indexed citations
5.
Bouferraa, Youssef, et al.. (2021). Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane. Clinical Medicine Insights Oncology. 15. 1353128642–1353128642. 3 indexed citations
6.
Husseini, Ziad El, Yolla Haibe, Youssef Bouferraa, et al.. (2021). Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience. Molecular and Clinical Oncology. 15(4). 220–220. 3 indexed citations
7.
Bouferraa, Youssef, et al.. (2021). Management of colorectal cancer in the era of COVID-19: Challenges and suggestions. Science Progress. 104(2). 311981122–311981122. 18 indexed citations
8.
Haibe, Yolla, et al.. (2021). Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?. International Journal of Molecular Sciences. 22(4). 2142–2142. 15 indexed citations
9.
Husseini, Ziad El, Yolla Haibe, Maya Charafeddine, et al.. (2020). Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience. Cancer Treatment and Research Communications. 25. 100222–100222. 3 indexed citations
10.
Haibe, Yolla, Malek Kreidieh, Hiba El Hajj, et al.. (2020). Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Frontiers in Oncology. 10. 221–221. 268 indexed citations
11.
Haibe, Yolla, et al.. (2020). Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review. International Journal of Molecular Sciences. 21(17). 6176–6176. 30 indexed citations
12.
Greally, Megan, Rajiv Agarwal, Imane El Dika, et al.. (2019). Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma. Journal of Gastrointestinal Oncology. 10(2). 367–372. 5 indexed citations
13.
Temraz, Sally, Yolla Haibe, Maya Charafeddine, et al.. (2019). The unveiling of a new risk factor associated with bladder cancer in Lebanon. BMC Urology. 19(1). 16–16. 9 indexed citations
14.
Salem, Rana, Yolla Haibe, Ali Shamseddine, et al.. (2019). Female oncologists in the Middle East and North Africa: progress towards gender equality. ESMO Open. 4(3). e000487–e000487. 9 indexed citations
15.
Naja, Farah, et al.. (2017). Prevalence and Correlates of Complementary and Alternative Medicine Use among Patients with Lung Cancer: A Cross‐Sectional Study in Beirut, Lebanon. Evidence-based Complementary and Alternative Medicine. 2017(1). 8434697–8434697. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026